We observed a reduction of caspase-3 cleavage in the ovarian tissues from patients with PCOS compared with those from controls, and further quantification by densitometric analysis revealed an 80% decrease in caspase-3 activation (P<0.01) (Fig 1C). Here, CASP3 is linked to polycystic ovary syndrome.